The Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics

ثبت نشده
چکیده

Ashton, J. C., Y. Zheng, et al. (2004). "Immunohistochemical characterisation and localisation of cannabinoid CB1 receptor protein in the rat vestibular nucleus complex and the effects of unilateral vestibular deafferentation." Brain Res 1021(2): 264-71. CB1 receptor expression has been reported to be low in the brainstem compared with the forebrain, and low in the vestibular nucleus complex (VNC) compared with other regions in the brainstem. However, a frequent effect of cannabis is dizziness and loss of balance. This may be due to the activation of cannabinoid receptors in the central vestibular pathways. We used immunohistochemistry to study the distribution of CB1 receptor protein in the VNC, and Western blotting to measure CB1 receptor expression in the VNC following unilateral vestibular deafferentation (UVD); the hippocampal CA1, CA2/3 and dentate gyrus (DG) regions were also analysed for comparison. This study confirms a previous electrophysiological demonstration that CB1 receptors exist in significant densities in the VNC and are likely to contribute to the neurochemical control of the vestibular reflexes. Nonetheless, CB1 receptor expression did not change significantly in the VNC during vestibular compensation. In addition, despite some small but significant changes in CB1 receptor expression in the CA2/3 and the DG following UVD, in no case were these differences statistically significant in comparison to both control groups.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics

Here is the latest summary of research abstracts. A reminder that the 2005 Symposium on the Cannabinoids to be held June 24th 27th, 2005 at the Hilton Clearwater Beach Resort in Clearwater, Florida USA; registration details are available at http://CannabinoidSociety.org/. In addition a workshop entitled “Cannabinoids: developing clinically useful analgesics” has been announced at the Internatio...

متن کامل

The Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics

Chen, R. Z., R. R. Huang, et al. (2004). "Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice." Brain Res 999(2): 227-30. Oral administration of the opioid antagonist nalmefene alone (up to 20 mg/kg) failed to show a significant effect on acute food intake in mice. However, combined oral dosing of nalmefene and subthreshold doses of AM...

متن کامل

The Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics

Ashton, J. C., I. Appleton, et al. (2004). "Immunohistochemical Localization of Cerebrovascular Cannabinoid CB1 Receptor Protein." J Cardiovasc Pharmacol 44(5): 517-9. Cannabinoids are powerful hypotensives and vasodilators. However, their mode of action is controversial. This study is the first to investigate the distribution of vascular CB1 receptor protein expression in situ. We used double-...

متن کامل

The Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics

Ashton, J. C., I. Appleton, et al. (2004). "Cannabinoid CB1 receptor protein expression in the rat choroid plexus: a possible involvement of cannabinoids in the regulation of cerebrospinal fluid." Neurosci Lett 364(1): 40-2. Cannabinoid CB1 receptors in the brain are expressed on axon terminals presynaptic to neurons that express fatty acid amide hydrolase (FAAH). Postsynaptic FAAH catabolizes ...

متن کامل

The Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics

Black, S. C. (2004). "Cannabinoid receptor antagonists and obesity." Curr Opin Investig Drugs 5(4): 389-94. The cannabinoid-1 (CB1) receptor plays a role in the regulation of appetitive behavior. Exogenously administered cannabinoid receptor agonists stimulate food consumption in animals and humans. Endogenous cannabinoid receptor agonists are present in the brain, and the brain level of these ...

متن کامل

The Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics

Ahmad, S. and A. Dray (2004). "Novel G protein-coupled receptors as pain targets." Curr Opin Investig Drugs 5(1): 67-70. G protein-coupled receptors (GPCRs) and their ligands play a number of important roles in the modulation of acute and chronic pain. Indeed, opioid and cannabinoid ligands are of established therapeutic value for pain management, and further exploitation of the specific GPCR s...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2004